|
Product characteristic
|
Percent of products (N = 6,182)
|
Mean (SD) USD Price Level in 2013
|
|---|
|
Manufacturer Count per Product
|
|
1
|
27%
|
92.90 (721.02)
|
|
2
|
6%
|
23.47 (108.27)
|
|
3
|
8%
|
16.13 (71.54)
|
|
4
|
6%
|
8.79 (37.44)
|
|
≥ 5
|
53%
|
2.65 (16.94)
|
|
Formulation
|
|
All Others
|
22%
|
41.23 (526.71)
|
|
Injectable
|
14%
|
133.76 (753.03)
|
|
Oral
|
64%
|
2.63 (14.24)
|
|
Patent Status
|
|
Branded Generic
|
21%
|
112.03 (822.57)
|
|
Generic
|
79%
|
8.36 (54.11)
|
|
Volume in previous period
|
|
Very low volume (<1,000 units per quarter)
|
10%
|
142.14 (1,077.18)
|
|
All other drugs
|
90%
|
17.65 (186.61)
|
|
Orphan Drug Designation
|
|
No
|
92%
|
13.53 (78.45)
|
|
Yes
|
8%
|
214.16 (1,293.70)
|
- aAuthors’ calculations using IQVIA Health NSP data. All analyses used STATA 14.0 (College Station, Texas)
